ABTのチャート
ABTの企業情報
| symbol | ABT |
|---|---|
| 会社名 | Abbott Laboratories （ABT アボットラボラトリ―ズ） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 アボットラボラトリーズ（Abbott Laboratories）はヘルスケア製品の発見、開発、製造及び販売に従事する企業である。同社は上場医薬品、診断薬、栄養剤、血管製品の4つの事業区分により構成される。上場医薬品は世界各地で製造され、各種ブランドのジェネリック医薬品を含む。診断製品には、診断システムとテストが含まれる。栄養製品には、小児用および成人用の栄養製品が含まれる。同社の血管製品には、血管疾患の治療のための冠状動脈、血管内血管、血管閉鎖および構造的心臓装置が含まれる。同社はSt. Jude Medical Incを通じてリズム管理製品、電気生理学製品、心不全関連製品、血管製品、構造用心臓製品、神経調節製品などの製品を提供する。 アボット・ラボラトリ―ズは米国の大手医薬品メ―カ―。リウマチ性関節炎用「ヒュミラ」、脂質異常症治療薬「トライコア」、HIV感染症治療薬「カレテラ」、前立腺がん治療薬「リュ―プロン」などを製造。ジェネリックも展開し、試薬、遺伝子検査キット、栄養補助食品「エンシュア」、血糖値自己測定器「フリ―スタイル」などを扱う。本社はイリノイ州。 Abbott is a global healthcare leader that helps people live more fully at all stages of life. Its portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries. |
| 本社所在地 | 224 667-6100 |
| 代表者氏名 | Miles D White |
| 代表者役職名 | Chairman of the Board Chief Executive Officer |
| 電話番号 | +1 224-667-6100 |
| 設立年月日 | 61 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 103000人 |
| url | www.abbott.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | EBITDA（百万ドル） 7008.00000 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | 時価総額（百万ドル） 140412.20000 |
| 売上高 | 売上高（百万ドル） 30578.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 155892.20000 |
| 当期純利益 | 当期純利益（百万ドル） 2464.00000 |
| 決算概要 | 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Abbott Laboratories revenues increased 12% to $30.58B. Net income before extraordinary items increased 36% to $2.46B. Revenues reflect Diagnostics Products segment increase of 33% to $7.5B Vascular Products segment increase of 6% to $9.44B Other segment increase of 21% to $2B All other Countries segment increase of 95% to $11.22B United States segment increase of 12% to $10.84B. |
ABTのテクニカル分析
ABTのニュース
Spine Surgery Market 2022 Key Stakeholders, CAGR, Growth Factors and Forecast 2028 | DePuy Synthes, Medtronic, Stryker, Zimmer-Biomet, Abbott Laboratories, Globus Medical Inc 2022/12/02 06:40:09 OpenPR
The Spine Surgery Market report will help you discover potential markets for new product launches and the best way to distribute a certain product. To understand all the above aspects, a formal management approach is taken to do the same.
Rapid Medical Diagnostic Devices Market Will Reflect Significant Growth Prospects By 2028 |Danaher Corporation, Abbott Laboratories, GE, Trinity Biotech Plc, Roche 2022/11/29 17:17:05 OpenPR
According to Market Study Report, Rapid Medical Diagnostic Devices Market provides a comprehensive analysis of the Rapid Medical Diagnostic Devices Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data
Liver Cirrhosis Treatment Market to Witness Huge Growth by Key Players: Pfizer, Abbott Laboratories, Novartis AG, Takeda Pharmaceuticals Company, Zydus Pharmaceuticals 2022/11/29 13:19:10 OpenPR
According to Market Study Report, Liver Cirrhosis Treatment Market provides a comprehensive analysis of the Liver Cirrhosis Treatment Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in
Intravascular Catheters Global Market Report 2022: Ukraine-Russia War Impact 2022/11/29 11:28:00 GlobeNewswire
Major players in the intravascular catheters market are Cook Medical, Smiths Medical, Edwards Life Sciences Corporation, Medtronic Inc, Johnson & Johnson, McKesson Medical Surgical Inc, Terumo Corporation, Abbott Laboratories Inc, Boston Scientific Corp, Getinge AB, Coloplast Corp, Cardinal Health, Conavi Medical, Infraredx Inc, BD, MAQUET Holding BV & Co KG, Vitality Medical, BBraun, Koninklijke Philips NV , Lumend Corporation, Covidien Ag, Acist Medical Systems, Biotronic SE & COKG, Biosense Webster Inc, Cordis, QX Medical and Teleflex Corporated. Major players in the intravascular catheters market are Cook Medical, Smiths Medical, Edwards Life Sciences Corporation, Medtronic Inc, Johnson & Johnson, McKesson Medical Surgical Inc, Terumo Corporation, Abbott Laboratories Inc, Boston Scientific Corp, Getinge AB, Coloplast Corp, Cardinal Health, Conavi Medical, Infraredx Inc, BD, MAQUET Holding BV & Co KG, Vitality Medical, BBraun, Koninklijke Philips NV , Lumend Corporation, Covidien Ag, Acist Medical Systems, Biotronic SE & COKG, Biosense Webster Inc, Cordis, QX Medical and Teleflex Corporated.
Spine Surgery Market 2022 Key Stakeholders, CAGR, Growth Factors and Forecast 2028 | DePuy Synthes, Medtronic, Stryker, Zimmer-Biomet, Abbott Laboratories, Globus Medical Inc 2022/12/02 06:40:09 OpenPR
The Spine Surgery Market report will help you discover potential markets for new product launches and the best way to distribute a certain product. To understand all the above aspects, a formal management approach is taken to do the same.
Rapid Medical Diagnostic Devices Market Will Reflect Significant Growth Prospects By 2028 |Danaher Corporation, Abbott Laboratories, GE, Trinity Biotech Plc, Roche 2022/11/29 17:17:05 OpenPR
According to Market Study Report, Rapid Medical Diagnostic Devices Market provides a comprehensive analysis of the Rapid Medical Diagnostic Devices Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data
Liver Cirrhosis Treatment Market to Witness Huge Growth by Key Players: Pfizer, Abbott Laboratories, Novartis AG, Takeda Pharmaceuticals Company, Zydus Pharmaceuticals 2022/11/29 13:19:10 OpenPR
According to Market Study Report, Liver Cirrhosis Treatment Market provides a comprehensive analysis of the Liver Cirrhosis Treatment Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in
Intravascular Catheters Global Market Report 2022: Ukraine-Russia War Impact 2022/11/29 11:28:00 GlobeNewswire
Major players in the intravascular catheters market are Cook Medical, Smiths Medical, Edwards Life Sciences Corporation, Medtronic Inc, Johnson & Johnson, McKesson Medical Surgical Inc, Terumo Corporation, Abbott Laboratories Inc, Boston Scientific Corp, Getinge AB, Coloplast Corp, Cardinal Health, Conavi Medical, Infraredx Inc, BD, MAQUET Holding BV & Co KG, Vitality Medical, BBraun, Koninklijke Philips NV , Lumend Corporation, Covidien Ag, Acist Medical Systems, Biotronic SE & COKG, Biosense Webster Inc, Cordis, QX Medical and Teleflex Corporated. Major players in the intravascular catheters market are Cook Medical, Smiths Medical, Edwards Life Sciences Corporation, Medtronic Inc, Johnson & Johnson, McKesson Medical Surgical Inc, Terumo Corporation, Abbott Laboratories Inc, Boston Scientific Corp, Getinge AB, Coloplast Corp, Cardinal Health, Conavi Medical, Infraredx Inc, BD, MAQUET Holding BV & Co KG, Vitality Medical, BBraun, Koninklijke Philips NV , Lumend Corporation, Covidien Ag, Acist Medical Systems, Biotronic SE & COKG, Biosense Webster Inc, Cordis, QX Medical and Teleflex Corporated.
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Abbott Laboratories (ABT) Investors of Class Action and to Actively Participate 2022/09/02 14:00:00 PR Newswire
NEW YORK, Sept. 2, 2022 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Abbott Laboratories ("Abbott" or "the Company") (NYSE: ABT) and certain of its officers, on behalf of all persons and…
ABBOTT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Abbott Laboratories and Encourages Investors to Contact the Firm 2022/09/02 04:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)-- #ABT--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Abbott Laboratories (“Abbott” or the “Company”) (NYSE: ABT) in the United States District Court for the Northern District of Illinois on behalf of all persons and entities who purchased or otherwise acquired Abbott securities between February 19, 2021 and June 8, 2022, both dates inclusive (the “Class Period”). Investors ha
Abbott Laboratories Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm 2022/09/01 21:48:00 GlobeNewswire
Investors can contact the law firm at no cost to learn more about recovering their losses
EQUITY ALERT: Rosen Law Firm Encourages Abbott Laboratories Investors to Inquire About Class Action Investigation – ABT 2022/09/01 20:12:00 Business Wire
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Abbott Laboratories (NYSE: ABT) resulting from allegations that Abbott may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Abbott securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abbott Laboratories - ABT 2022/09/01 19:06:00 GlobeNewswire
NEW YORK, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abbott Laboratories (“Abbott” or the “Company”) (NYSE: ABT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.